NO-how: Nitrate Supplementation; Duration

Sponsor
Maastricht University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02115893
Collaborator
(none)
20
2
2
11
10
0.9

Study Details

Study Description

Brief Summary

The main aim of the current study will be to find the optimal duration of supplementation to enhance sports performance.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Sodium Nitrate
  • Dietary Supplement: Sodium Chloride
Phase 4

Detailed Description

Oral ingestion of nitrate (NO3-) in the form of both nitrate salts and beetroot juice has been shown to significantly lower blood pressure at rest and to also lower pulmonary oxygen uptake during exercise, in addition to improving exercise performance during cycle time trial. However, there has been no consensus on the optimal supplementation protocols, in terms of duration of supplementation to see these metabolic effects. Furthermore, a positive exercise performance effect of nitrate ingestion has primarily been observed in recreational athletes. The potentially ergogenic effects of nitrate in well-trained or elite athletes therefore remain to be fully established. Based on the gaps in current literature, our main goal will be to gain further insight into different aspects of nitrate supplementation to enhance (elite) sports performance. This will be investigated in this study by assessing the effect of an acute vs. chronic supplementation period of sodium nitrate (NaNO3-) on exercise performance.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Official Title:
The Effect of Nitrate Supplementation on Sports Performance: Duration of Supplementation
Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Nov 1, 2014
Actual Study Completion Date :
Mar 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Sodium Nitrate

Dietary Supplement: Sodium nitrate 800 mg of nitrate in sodium nitrate added with water to get a 140 mL solution (BASF, Ludwigshafen, Germany)

Dietary Supplement: Sodium Nitrate

Placebo Comparator: Sodium Cloride

Dietary Supplement: Sodium chloride 800 mg of sodium chloride added with water to get a 140 mL solution (Frisia Zout BV, Harlingen, The Netherlands)

Dietary Supplement: Sodium Chloride

Outcome Measures

Primary Outcome Measures

  1. Time-trial exercise performance [Time trial starts 4 hours after ingestion and ends on average after 15 minutes of cycling (depending on subject's cycling speed)]

    The primary outcome measure will be the time to complete the time-trial following dietary nitrate or placebo ingestion

Secondary Outcome Measures

  1. Resting blood pressure [30 min pre-ingestion until 2.5 hours post-ingestion]

    Resting blood pressure measures following ingestion of dietary nitrate

  2. Plasma nitrate and nitrite levels [30 min pre-ingestion until 30 min post-time-trial testing]

    Plasma nitrate and nitrite levels following ingestion of dietary nitrate

  3. Submaximal exercise performance [starting from 3 hours post-ingestion on testing days until completion of the submaximal exercise]

    Oxygen consumption CO2 production and heart rate during submaximal exercise

  4. Time-trial exercise performance; power output and heart rate [starting from 4 hours post-ingestion on testing days until completion of the time-trial]

    Power output and heart rate during the time-trial exercise

Other Outcome Measures

  1. Baseline characteristics and fitness level assessment [3 hours during visit 1 (Screening)]

    Resting blood pressure, height, body weight, age, BMI, measures of GI tolerance, VO2 max, Wmax, rate of perceived exertion

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18.5 < BMI < 25 kg/m2

  • Endurance trained cyclists/triathletes (with at least 1 year of competitive cycling experience)

  • VO2max ≥ 55 mL/kg/min

Exclusion Criteria:
  • Use of medication

  • Injury prohibiting them from performing the exercise protocol effectively

  • Smoking

  • Currently supplementing diet with nitrate

  • Lactose intolerance

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maastricht University Medical Centre+ Maastricht Limburg Netherlands 6200 MD
2 Maastricht University Medical Centre+ Maastricht Limburg Netherlands 6200MD

Sponsors and Collaborators

  • Maastricht University Medical Center

Investigators

  • Principal Investigator: Lex B Verdijk, PhD, Maastricht University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT02115893
Other Study ID Numbers:
  • METC13-3-059
First Posted:
Apr 16, 2014
Last Update Posted:
Mar 16, 2016
Last Verified:
Oct 1, 2014
Keywords provided by Maastricht University Medical Center

Study Results

No Results Posted as of Mar 16, 2016